Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06510361 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 13, 2026 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study sites: 1 to 3v4
  2. Primary completion date: May 1, 2025 to May 1, 2026 Site contact updatedv3 Show 1 more changeShow less
    • Site contact updated
  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Dec 2024 to Nov 20, 2024 · Secondary endpoints: details revised at 1 of 9 entries · Site details revised · 1 morev2 Show 4 more changesShow less
    • Start date changed from estimate of Dec 2024 to Nov 20, 2024
    • Secondary endpoints: details revised at 1 of 9 entries
    • Site details revised
    • Study title shortened, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment. The name of the study drug in this research study is: -Epcoritamab (a type of antibody)
Trial Details
NCT Number NCT06510361
Lead Sponsor Beth Israel Deaconess Medical Center
Collaborators: Genmab
Conditions Lymphoma, Follicular Lymphoma, Lymphoma,Non-Hodgkin, Lymphoma, Non-Hodgkin's, Adult
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov